Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis

ClinicalTrials.gov ID: NCT02246439

Public ClinicalTrials.gov record NCT02246439. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Randomized, Placebo-Controlled, Phase 3 Trial of RHB-102 (BEKINDA) (Ondansetron 24 mg Bimodal Release Tablets) for Acute Gastroenteritis. The study will evaluate the safety and efficacy of RHB-102 (BEKINDA) in treating Acute Gastroenteritis, by comparing it to placebo.

Study identification

NCT ID
NCT02246439
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
RedHill Biopharma Limited
Industry
Enrollment
330 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 8, 2014 (Actual)
Primary completion
Feb 13, 2017 (Actual)
Completion
Feb 16, 2017 (Actual)
Last update posted
Feb 20, 2019

2014 – 2017

United States locations

U.S. sites
26
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
Kern Medical Center Bakersfield California 93311 —
UC Davis Sacramento California 95817 —
Olive View- UCLA Medical Center Sylmar California 91342 —
George Washington University Washington D.C. District of Columbia 20037 —
University of Florida Jacksonville Jacksonville Florida 32209 —
University of Maryland Medical Center Baltimore Maryland 21201 —
South Shore Hospital South Weymouth Massachusetts 02190 —
Henry Ford Health System Detroit Michigan 48202 —
Wayne State University - Sinai Grace Hospital Detroit Michigan 48235 —
Hennepin County Medical Center Minneapolis Minnesota 55415 —
Washington University - St. Louis St Louis Missouri 63110 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
Kings County Hospital Brooklyn New York 11203 —
University Hospital of Brooklyn Brooklyn New York 11203 —
North Shore University Hospital Manhasset New York 11030 —
Cohen's Children's Medical Center of NY New Hyde Park New York 11040 —
Long Island Jewish Medical Center New Hyde Park New York 11040 —
Staten Island University Hospital North Staten Island New York 10305 —
Stony Brook University Stony Brook New York 11794 —
Oregon Health and Science University Portland Oregon 97239 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
UPMC Mercy Pittsburgh Pennsylvania 15219 —
University of Pittsburgh Pittsburgh Pennsylvania 15261 —
CityDoc Urgent Care Dallas Texas 75209 —
Baylor College of Medicine Houston Texas 77030 —
McAllen Primary Care McAllen Texas 78503 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02246439, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 20, 2019 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02246439 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →